My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eli Lilly (NY:LLY)

1,074.93 +3.29 (+0.31%)

Streaming Delayed Price Updated: 12:03 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Breakthrough in Alzheimer’s Diagnostics: University of Liverpool Unveils Low-Cost, Handheld AI Blood Test

October 06, 2025

In a monumental stride towards democratizing global healthcare, researchers at the University of Liverpool have announced the development of a pioneering low-cost, handheld, AI-powered blood test...

Via TokenRing AI

Topics Artificial Intelligence

Eli Lilly: Beyond Weight Loss ↗

October 06, 2025

Eli Lilly is riding a big trend.

Via The Motley Fool

The Healthcare Stock Play That Could Make Millennials Rich ↗

October 06, 2025

This investment may also make baby boomers, and those from Gen X and Gen Z, rich as well.

Via The Motley Fool

Topics ETFs

Eli Lilly Bets Big On India With $1B Investment To Boost Mounjaro, Drug Manufacturing Network ↗

October 06, 2025

Via Stocktwits

Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts ↗

October 06, 2025

Via Stocktwits

2 Beaten-Down Stocks Primed for a Comeback ↗

October 05, 2025

The market is sleeping on these stocks, but you don't have to.

Via The Motley Fool

Viking Therapeutics Stock: A Stumble Or The Setup Of The Decade? ↗

October 04, 2025

Viking Therapeutics is not a household name yet. But this small biotech is trying to play in the biggest money game in healthcare right now: weight loss drugs. The same field where Novo Nordisk and Eli...

Via Talk Markets

Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors

October 04, 2025

As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for...

Via MarketMinute

Topics Artificial Intelligence Climate Change Economy

Navigating the Storm: Essential Strategies to Avoid 'Bag Holder' Status in Volatile Markets

October 04, 2025

The financial markets, as of October 4, 2025, continue to be characterized by a significant degree of volatility, presenting both opportunities and perilous traps for investors. In such an environment,...

Via MarketMinute

Topics ETFs Economy

Market Defies D.C. Gridlock: S&P 500 and Dow Jones Soar to Record Highs Amidst Government Shutdown

October 04, 2025

The U.S. financial markets are currently presenting a perplexing paradox. As of October 4, 2025, both the S&P 500 and Dow Jones Industrial Average (DJIA) have surged to unprecedented record highs,...

Via MarketMinute

Topics Artificial Intelligence Economy Government

4 Reasons to Buy Amgen Stock Right Now ↗

October 04, 2025

For those with a sufficiently long investment horizon, the stock looks attractive.

Via The Motley Fool

Topics Intellectual Property

Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets ↗

October 03, 2025

S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easing and AI tech.

Via Benzinga

Topics Artificial Intelligence Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

October 03, 2025

Via Benzinga

Danish Equities Soar as OMX Copenhagen 20 Posts Strong Gains Amidst Bullish Market Sentiment

October 03, 2025

Copenhagen's stock market demonstrated robust performance in early October 2025, with the benchmark OMX Copenhagen 20 (OMXC20) index experiencing a significant uplift. While specific daily fluctuations...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Why Shares of Eli Lilly Soared This Week ↗

October 03, 2025

Pfizer's deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs.

Via The Motley Fool

Topics Government World Trade

Eli Lilly And Its Competitors Pop On The Pfizer News ↗

October 03, 2025

Eli Lilly and other US-based drug makers have led the market over the last few days.

Via Talk Markets

Spotlight on Eli Lilly: Analyzing the Surge in Options Activity ↗

October 03, 2025

Via Benzinga

Eli Lilly Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) ↗

October 03, 2025

Via Benzinga

My 6 Top-Ranked Stocks to Buy Now in October (2025)! ↗

October 03, 2025

This excellent list of stocks includes growth stocks, AI stocks, and dividend stocks.

Via The Motley Fool

Topics Artificial Intelligence

Federal Shutdown Paralysis: Data Delays Deepen Economic Damage Fears

October 02, 2025

The United States economy finds itself navigating treacherous waters as a federal government shutdown grips the nation, sparking heightened concerns about widespread economic damage. What makes this...

Via MarketMinute

Topics Economy Initial Public Offering Regulatory Compliance

Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience

October 02, 2025

On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Novo Nordisk (NVO) Soars as HSBC Upgrades to "Buy," Citing Strategic Focus and Pipeline Strength

October 02, 2025

Copenhagen, Denmark – October 2, 2025 – Shares of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) experienced a significant surge yesterday, October 1, 2025, following a pivotal upgrade from HSBC....

Via MarketMinute

Topics Economy

Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know

October 02, 2025

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.

Via StockStory

Topics Government World Trade

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

October 02, 2025

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.

Via StockStory

Topics World Trade

These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap ↗

October 02, 2025

Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount.

Via Benzinga

Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures

October 02, 2025

A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human...

Via MarketMinute

Topics Artificial Intelligence Derivatives

Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes

October 02, 2025

Paris, France – October 2, 2025 – Nanobiotix (NASDAQ: NBTX) witnessed a significant surge in its stock price today, jumping 11.6%, following the announcement of highly encouraging initial data from a...

Via MarketMinute

3 Blue Chip Stocks That Have Soared 380% (and Higher) Over the Past 5 Years ↗

October 02, 2025

By investing in quality growth stocks, you can put yourself in an excellent position to earn a great return.

Via The Motley Fool

Topics Artificial Intelligence

Wall Street Holds Firm Despite Shutdown and Weak Jobs Data ↗

October 02, 2025

Stocks shrugged off Washington’s chaos as hopes for Fed rate cuts and strong corporate news kept investors in a buying mood.

Via Chartmill

Topics Economy

Biogen Soars 9.02% on Groundbreaking Alzheimer's Drug Advancements: A New Era for Dementia Treatment Dawns

October 01, 2025

Boston, MA – October 1, 2025 – Biogen Inc. (NASDAQ: BIIB) saw its stock surge by an impressive 9.02% today, propelled by a wave of promising advancements in its Alzheimer's disease drug testing...

Via MarketMinute

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.